Final answer:
The combination of transdermal conjugated estrogen and medroxyprogesterone (CombiPatch) provides relief from postmenopausal symptoms including hot flashes, night sweats, and may prevent osteoporosis. It may also improve mood and libido. However, it does not regulate the menstrual cycle and carries certain health risks.
Step-by-step explanation:
The therapeutic effects of the drug combination of transdermal conjugated estrogen and medroxyprogesterone (CombiPatch) primarily include relief of postmenopausal symptoms such as hot flashes and night sweats caused by hormonal decline. These medicines also help in preventing osteoporosis, a condition that may arise due to loss of bone density associated with inadequate estrogen levels. However, this combination does not regulate the menstrual cycle as menopause marks the end of a woman's reproductive period and her menstrual cycles.
In addition to the relief of physical symptoms, this hormonal therapy may also bring about improvement in mood and consequently, libido, which often declines during menopause due to fluctuating hormones. However, while providing these therapeutic benefits, hormone replacement therapy is also associated with some risks including an increased risk of blood clots, stroke, and certain types of cancers. Therefore, the treatment needs to be individualized considering each woman's associated risk summary.
Learn more about Therapeutic effects of CombiPatch